Search

Your search keyword '"Roobol MJ"' showing total 487 results

Search Constraints

Start Over You searched for: Author "Roobol MJ" Remove constraint Author: "Roobol MJ"
487 results on '"Roobol MJ"'

Search Results

1. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

2. Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database

3. Genetic factors associated with prostate cancer conversion from active surveillance to treatment

4. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

5. Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer

6. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

7. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

8. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

9. Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance.

10. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

11. The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

12. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

13. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)

15. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts

16. PSAInForm: Einfluss einer partizipativen Entscheidungshilfe sowie der Kostenübernahme auf den Entscheidungskonflikt zur Durchführung eines PSA-Tests im Regierungsbezirk Münster

17. Germline variation at 8q24 and prostate cancer risk in men of European ancestry (vol 9, 4616, 2018)

18. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia (vol 9, 1340, 2018)

19. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (vol 9, 3707, 2018)

20. Large-scale transcriptome-wide association study identifies new prostate cancer risk regions (vol 9, 4079, 2018)

21. Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility (vol 8, 1892, 2017)

22. Shared heritability and functional enrichment across six solid cancers

23. Association analyses identify 31 new risk loci for colorectal cancer susceptibility

24. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

25. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

26. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

27. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

29. Active surveillance for prostate cancer: a narrative review of clinical guidelines

31. Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.

32. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.

35. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

36. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

37. Centralized prostatectomy with intraoperative NeuroSAFE margin assessment improves surgical margin control.

38. PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research.

39. Risk calculators for the detection of prostate cancer: a systematic review.

40. Prostate Cancer Early Detection in the European Union and UK.

41. Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer.

42. From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of Life.

43. Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry.

44. Understanding the Barriers to Prostate Cancer Population-Based Early Detection Programs: The PRAISE-U BEST Survey.

45. Influences on androgen deprivation therapy prescribing before surgery in high-risk prostate cancer.

46. A 2-year prospective evaluation of the Prostate Health Index in guiding biopsy decisions in a large cohort.

47. Evolution of European prostate cancer screening protocols and summary of ongoing trials.

48. Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe.

49. Reply to Borivoj Golijanin, Anthony Mega, and Dragan Golijanin's Letter to the Editor re: Ivo I. de Vos, Sebastiaan Remmers, Renée Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group. Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam. Eur Urol 2024;85:74-81.

50. Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.

Catalog

Books, media, physical & digital resources